ClinicalTrials.gov
public full text
Public Domain
The RApid Switch From 1st Generation Somatostatin Analogues to PaSireOtiDe In Acromegaly
This is an observational, retrospective, national multicenter study aimed to evaluate the impact and efficacy of Time To Switch (TTS) from first-line to second-line medical therapy in Acromegaly.
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Predictive Factors of Response to Somatostatin Analogues in Acromegalic Patients With Persistent Disease Following Surgery#979338
- Efficacy of Octreotide Acetate and Cabergoline in Patients With Acromegaly#1031085
- Comparison of Oral Octreotide Capsules to Injectable Somatostatin Analogs in Acromegaly#876030
- Somatostatin Analogues in the Treatment of Relapsing GH Pituitary Adenomas After Surgery#848777
- Effects of Terlipressin When Usual Somatostatin or Octreotide Dose Fails#181642
Record · ID 1059255
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive